Search

everythinglearnresearchcommunity

for

Search:↓

Sirolimus effectively reduces lesions and improves quality of life in Blue Rubber Bleb Nevus Syndrome with manageable side effects.

Renal transplant patients on tacrolimus and sirolimus may develop acne keloidalis nuchae.

Sirolimus and propranolol may reduce abnormal cell growth and improve lymphatic malformations in children.

Collagen VII helps skin heal and stay strong, sirolimus may lower skin cancer risk in kidney transplant patients, high-molecular-mass hyaluronan helps naked mole rats resist cancer, dermal γδ T cells aid in hair growth in rodents, and overexpression of IL-33 in mouse skin causes itchiness, offering a model for studying allergic inflammation treatments.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

An 8-year-old boy developed a rare condition after a liver transplant, which improved after changing his medication.

Reducing immunosuppression and using antiviral creams improved the woman's skin condition.

In 2017, pediatric dermatology advanced with new treatments and insights into various skin conditions in children.

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

A 68-year-old man improved after being correctly diagnosed and treated for a skin condition caused by mites, following a stem cell transplant.

A protein complex called mTORC1 likely affects when hair growth starts in mice.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

Kidney cancer cells without folliculin are more sensitive to radiation due to increased self-eating cell death.

Blocking mTORC1 may help prevent skin cancer by stopping the growth of certain skin stem cells.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

D-OCT shows increased blood vessel growth in response to tissue damage in Frontal Fibrosing Alopecia and is useful for diagnosis and monitoring.

PRC1 influences skin stem cell development by both turning genes on and off, affecting hair growth and skin cell types.

Blocking JAK-STAT5 signaling in mice leads to hair growth.

The hair follicle dermal sheath is essential for hair shedding and needs to communicate with the outer root sheath for normal hair growth cycles.

A woman was allergic to quinine in her anti-hair loss lotion.

Hair loss patterns differ between males and females due to 5 master regulators and JAK-STAT signaling affects hair growth.

The mTOR signaling pathway is crucial for hair health and targeting it may lead to new hair loss treatments.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Acne is not a key diagnostic feature for PCOS, postadolescent men with acne may have insulin resistance, melanoma patients often have few moles, tumor size in CSCC indicates higher risk of serious outcomes, and hidradenitis suppurativa is linked to higher risk of heart problems and death.

Mice without the vitamin D receptor have bone issues and other health problems, suggesting vitamin D is important for preventing various diseases in humans.

The conclusion is that using drugs to block the TOR pathway might slow aging and prevent age-related diseases.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Some viruses can cause cancer by changing cell processes and avoiding the immune system; vaccines and targeted treatments help reduce these cancers.

Transplant success has improved with better immunosuppressive drugs and donor matching.